SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-000675
Filing Date
2024-01-02
Accepted
2024-01-02 16:02:32
Documents
12
Period of Report
2024-01-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d120932d8k.htm   iXBRL 8-K 29982
  Complete submission text file 0001193125-24-000675.txt   157232

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lbph-20240102.xsd EX-101.SCH 2873
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lbph-20240102_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lbph-20240102_pre.xml EX-101.PRE 11722
6 EXTRACTED XBRL INSTANCE DOCUMENT d120932d8k_htm.xml XML 3480
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 24502345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)